It is interesting to note that CsA-treatment, but not Itk-deficiency (the non-Itk/CN anti-CD3 group), results in severely reduced transcript levels for IFNγ. The gene discussed is ITK; the disease is hyperinsulinemic hypoglycemia, familial, 4.